KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Figure 6

Distribution of IC50 scores of targeted drugs in different KDELR3 expression groups via ACLBI website.